Review
Published on 28 Oct 2022
Pharmacologic therapies of ARDS: From natural herb to nanomedicine
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.930593
- 6,307 views
- 13 citations
Type at least 3 characters
593 articles
Articles
Original Research
Published on 28 Oct 2022
Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1053356
- 3,496 views
- 5 citations
Original Research
Published on 28 Oct 2022
Differentiation and on axon-guidance chip culture of human pluripotent stem cell-derived peripheral cholinergic neurons for airway neurobiology studies
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.991072
- 5,030 views
- 8 citations
Clinical Trial
Published on 21 Oct 2022
The safety and efficacy of alfentanil combined with midazolam in fiberoptic bronchoscopy sedation: A randomized, double-blind, controlled trial
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1036840
- 2,291 views
- 5 citations
Original Research
Published on 20 Oct 2022
Effects of Juhongtanke oral solution on alleviating the symptoms of community-acquired pneumonia: A multicenter, prospective, randomized controlled trial
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1027901
- 2,493 views
Mini Review
Published on 19 Oct 2022
Prevention and treatment of ventilator-associated pneumonia in COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.945892
- 5,888 views
- 2 citations
Original Research
Published on 17 Oct 2022
Pharmacological OGG1 inhibition decreases murine allergic airway inflammation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.999180
- 4,054 views
- 13 citations
Case Report
Published on 17 Oct 2022
The therapeutic effect of glucocorticoids on type II respiratory failure, heart failure, and massive pericardial effusion caused by hypothyroidism: A case report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.900701
- 2,006 views
Editorial
Published on 17 Oct 2022
Editorial: Pulmonary fibrosis: One manifestation, various diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1027332
- 2,363 views
- 11 citations
Original Research
Published on 14 Oct 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.979788
- 8,364 views
- 296 citations
Original Research
Published on 11 Oct 2022
Small airway dysfunction in idiopathic pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1025814
- 2,417 views
- 6 citations
Review
Published on 11 Oct 2022
Gene therapy for cystic fibrosis: Challenges and prospects
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1015926
- 28,966 views
- 22 citations
Original Research
Published on 11 Oct 2022
In vitro neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1021317
- 3,200 views
- 1 citation
Review
Published on 10 Oct 2022
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.987816
- 7,082 views
- 9 citations
Original Research
Published on 06 Oct 2022
Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.996046
- 3,389 views
- 1 citation
Review
Published on 05 Oct 2022
Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.966637
- 4,232 views
- 1 citation